BT

BRAD TRAVERSE

INFUSION PROVIDERS ALLIANCE · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
4
4 agencies contacted
Activity
filings by quarter
Works on

Background

Government experience
Former Senior Advisor
Office of the HHS Assistant Secretary of Public Affairs
Disclosed on LD-2 filings
Career
Washington, DC
2024 - present

Specific issues

Implementation of provisions included in Subtitle B of PL. 117-169 - The Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. l0545 - the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R. l 0445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act Access to Alzheimer's Disease therapies.
Medicare/Medicaid · 2024 Q4
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
Health Issues · 2024 Q4
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Access to Alzheimer's Disease therapies.
Medicare/Medicaid · 2024 Q3
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging.
Health Issues · 2024 Q3
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to downcoding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging. Access to Alzheimer's Disease therapies. Issues related to virtual supervision of infusion drugs. Advocating for access to biosimilars. Access to Alzheimer's Disease therapies.
Medicare/Medicaid · 2024 Q2
Issues related to the Change Healthcare cyber-attack.
Health Issues · 2024 Q2

Clients

$██,███ / qtrUnlock

Filing history

2024 Q4
INFUSION PROVIDERS ALLIANCE
Q4lda.gov →
2024 Q3
INFUSION PROVIDERS ALLIANCE
Q3lda.gov →
2024 Q2
INFUSION PROVIDERS ALLIANCE
Q2lda.gov →
2024 Q1
INFUSION PROVIDERS ALLIANCE
Q1lda.gov →
Showing recent filings · full history on lda.gov